Keeping Up With Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis

To participate in this activity, please:

Multiple sclerosis (MS) is a chronic, progressive, and disabling inflammatory neurologic condition that causes more disability than any other nontraumatic neurologic condition. Early diagnosis, treatment, and monitoring of disease progression are fundamental to optimizing management of patients with MS. Here, we present an online learning module that covers key principles in all phases of management, with a focus on up-to-date and evidence-based principles of providing high-quality care.

Course Credit:

1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
0.25 Pharmacology Hours

Dates:

Opens: 2022-08-25
Closes: 2023-08-25

Target Audience:

This activity was developed for neurologists, physician assistants, nurse practitioners, and allied healthcare professionals who diagnose and manage patients with multiple sclerosis (MS).

Supported by educational grants from Genentech, a member of the Roche Group, and Novartis.

Accreditation

In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 contact hour, including 0.25 pharmacology hours.

Additional Content Planners

Amber Lea Lambert, MSN, FNP-C, DNP (Nurse Reviewer)
No significant relationships to disclose.

Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.

Sunali Wadehra, MD (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Presenting Faculty

  • Edward J. Fox, MD, PhD

    Director, MS Clinic of Central Texas
    Central Texas Neurology Consultants, PA
    Clinical Associate Professor, University of Texas Dell Medical School
    Round Rock, Texas

  • Contributing Faculty

    Matthew K. Schindler, MD, PhD

    Assistant Professor of Neurology, MS Division
    Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania

Learning Objectives

  • Select a treatment plan for a patient with MS that is consistent with the state-of-the-art in MS care
  • Recognize a patient with a highly active MS presentation or a poor prognosis
  • Select a treatment based on its demonstrated clinical efficacy and a patient’s MS presentation
  • Recognize adverse event prevention, monitoring, and/or mitigation strategies

Faculty Disclosures

Edward J. Fox, MD, PhD

Advisory Board: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Novartis

Consultant: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Novartis

Speakers Bureau: Alexion, Biogen, Bristol Myers Squibb, Genentech, Horizon, Janssen, Sanofi Genzyme


Matthew K. Schindler, MD, PhD

No relationships to disclose.